| 4965 |
33 |
Co/PMCS |
Sepsis Management |
|
|
|
|
|
|
|
|
| 5203 |
311 |
organic nanozymes |
prevent oxidative damage for TBI therapy to reduce the ROS level in damaged brain tissues |
|
|
|
|
|
|
|
|
| 5204 |
312 |
PtRu NPs |
detection of Fe2+ and protection of Monascus pigments |
Fe2+ |
Color |
0.2-6.0 |
mM |
0.05 |
μM |
|
|
| 5467 |
524 |
Pd@Pt-GOx/hyaluronic acid (HA |
for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy |
|
|
|
|
|
|
|
|
| 5821 |
903 |
AuNPs |
Analysis of gas Samples |
CO |
SERS |
|
|
|
|
|
|
| 5827 |
913 |
Cu-HCSs |
Photolysis of methicillin-resistant Staphylococcus aureus |
Staphylococcus aureus |
|
|
|
|
|
|
|
| 5828 |
914 |
MnO2@Au |
enhanced photothermal performance and reactive oxygen species generation |
tumour |
|
|
|
|
|
|
|
| 5833 |
923 |
Au–CeO2 |
antiinflammatory |
nasal polyps |
|
|
|
|
|
|
|
| 6116 |
1244 |
Au-MCM-41 hybrids |
Multiple reaction conditions have been thoroughly explored to identify the best performing scenario and the main reaction products (i.e., gluconic acid and hydrogen peroxide) expected from the selective oxidation of glucose. |
|
|
|
|
|
|
|
|